scholarly journals The Munich Myocardial Infarction Registry: Translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice

Diabetes Care ◽  
2009 ◽  
Vol 32 (suppl_2) ◽  
pp. S326-S330 ◽  
Author(s):  
O. Schnell ◽  
W. Otter ◽  
E. Standl
Keyword(s):  
Myocardial Infarction ◽  
Cardiovascular Disease ◽  
Clinical Practice ◽  
European Society ◽  
European Association ◽  
European Society Of Cardiology

Stress bei Patienten: Stress als Prognosefaktor für Re-Infarkte bei koronarer Herzkrankheit

2018 ◽  
Vol 7 (05) ◽  
pp. 379-383
Author(s):  
Jian Li ◽  
Peter Angerer
Keyword(s):  
Cardiovascular Disease ◽  
Clinical Practice ◽  
Disease Prevention ◽  
Cardiac Rehabilitation ◽  
European Society ◽  
European Association ◽  
Cardiovascular Prevention ◽  
Cardiovascular Disease Prevention ◽  
European Guidelines ◽  
European Society Of Cardiology

ZusammenfassungBisher wurde Stress als Prognosefaktor bei koronarer Herzkrankheit nur wenig beachtet. Wir möchten in diesem Artikel einen aktualisierten und umfassenden Überblick darüber geben, welche Rolle Stress bei der Prognose der koronaren Herzkrankheit spielen könnte. Stress wurde in unterschiedlichen Domänen gemessen. Die Synthese der Forschungsevidenz lässt vermuten, dass Stress das Risiko für wiederholte klinische Ereignisse bei Patienten mit koronarer Herzkrankheit um 55% (95%-Konfidenzintervall 32 – 83%) erhöhen kann. Die „European Guidelines on Cardiovascular Disease Prevention in Clinical Practice“, 2016 von der European Society of Cardiology veröffentlicht, weisen besonders auf die Rolle von Stress und psychosozialen Risikofaktoren hin. Insbesondere die „Cardiac Rehabilitation Section“ der European Association of Cardiovascular Prevention and Rehabilitation schlägt eine 2-stufige Evaluation eines potenziellen Risikos durch Stress für die klinisch-kardiologische Praxis vor.

Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)

2007 ◽  
Vol 14 (2_suppl) ◽  
pp. S1-S1 ◽  
Author(s):  
Ian Graham ◽  
Dan Atar ◽  
Knut Borch-Johnsen ◽  
Gudrun Boysen ◽  
Gunilla Burell ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Clinical Practice ◽  
Disease Prevention ◽  
Practice Guidelines ◽  
European Society ◽  
Task Force ◽  
Cardiovascular Disease Prevention ◽  
Joint Task ◽  
Joint Task Force ◽  
European Society Of Cardiology

Other experts who contributed to parts of the guidelines: Edmond Walma, Tony Fitzgerald, Marie Therese Cooney, Alexandra Dudina European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG): Alec Vahanian (Chairperson), John Camm, Raffaele De Caterina, Veronica Dean, Kenneth Dickstein, Christian Funck-Brentano, Gerasimos Filippatos, Irene Hellemans, Steen Dalby Kristensen, Keith McGregor, Udo Sechtem, Sigmund Silber, Michal Tendera, Petr Widimsky, Jose Luis Zamorano Document reviewers: Irene Hellemans (CPG Review Co-ordinator), Attila Altiner, Enzo Bonora, Paul N. Durrington, Robert Fagard, Simona Giampaoli, Harry Hemingway, Jan Hakansson, Sverre Erik Kjeldsen, Mogens Lytken Larsen, Giuseppe Mancia, Athanasios J. Manolis, Kristina Orth-Gomer, Terje Pedersen, Mike Rayner, Lars Ryden, Mario Sammut, Neil Schneiderman, Anton F. Stalenhoef, Lale Tokgözoglu, Olov Wiklund, Antonis Zampelas

The European Society of Cardiology and the European Association for the Study of Diabetes: guidelines for diabetes and cardiovascular diseases

2020 ◽  
Vol 15 (3) ◽  
pp. 1-4
Author(s):  
Belinda Linden
Keyword(s):  
Cardiovascular Disease ◽  
Cardiovascular Diseases ◽  
European Society ◽  
European Association ◽  
European Society Of Cardiology ◽  
Cardiovascular Nursing

Belinda Linden presents a quarterly overview of recently published guidance of relevance to cardiovascular nursing. The significant link between diabetes and cardiovascular disease is reviewed in this update

Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)

2007 ◽  
Vol 14 (2_suppl) ◽  
pp. E1-E40 ◽  
Author(s):  
Ian Graham ◽  
Dan Atar ◽  
Knut Borch-Johnsen ◽  
Gudrun Boysen ◽  
Gunilla Burell ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Czech Republic ◽  
Clinical Practice ◽  
The Netherlands ◽  
Disease Prevention ◽  
European Society ◽  
Task Force ◽  
Joint Task ◽  
Joint Task Force ◽  
European Society Of Cardiology

Other experts who contributed to parts of the guidelines: Edmond Walma, Schoonhoven (The Netherlands), Tony Fitzgerald, Dublin (Ireland), Marie Therese Cooney, Dublin (Ireland), Alexandra Dudina, Dublin (Ireland) European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG):, Alec Vahanian (Chairperson) (France), John Camm (UK), Raffaele De Caterina (Italy), Veronica Dean (France), Kenneth Dickstein (Norway), Christian Funck-Brentano (France), Gerasimos Filippatos (Greece), Irene Hellemans (The Netherlands), Steen Dalby Kristensen (Denmark), Keith McGregor (France), Udo Sechtem (Germany), Sigmund Silber (Germany), Michal Tendera (Poland), Petr Widimsky (Czech Republic), José Luis Zamorano (Spain) Document reviewers: Irene Hellemans (CPG Review Coordinator) (The Netherlands), Attila Altiner (Germany), Enzo Bonora (Italy), Paul N. Durrington (UK), Robert Fagard (Belgium), Simona Giampaoli(Italy), Harry Hemingway (UK), Jan Hakansson (Sweden), Sverre Erik Kjeldsen (Norway), Mogens Lytken Larsen (Denmark), Giuseppe Mancia (Italy), Athanasios J. Manolis (Greece), Kristina Orth-Gomer (Sweden), Terje Pedersen (Norway), Mike Rayner (UK), Lars Ryden (Sweden), Mario Sammut (Malta), Neil Schneiderman (USA), Anton F. Stalenhoef (The Netherlands), Lale Tokgözoglu (Turkey), Olov Wiklund (Sweden), Antonis Zampelas (Greece)

scholarly journals Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology

2019 ◽  
Vol 27 (2) ◽  
pp. 181-205 ◽  
Author(s):  
Massimo F Piepoli ◽  
Ana Abreu ◽  
Christian Albus ◽  
Marco Ambrosetti ◽  
Carlos Brotons ◽  
...  
Keyword(s):  
Clinical Practice ◽  
European Society ◽  
European Association ◽  
Task Force ◽  
Cardiovascular Prevention ◽  
Population Level ◽  
Population Based ◽  
Preventive Cardiology ◽  
European Society Of Cardiology ◽  
Disease Specific

European guidelines on cardiovascular prevention in clinical practice were first published in 1994 and have been regularly updated, most recently in 2016, by the Sixth European Joint Task Force. Given the amount of new information that has become available since then, components from the task force and experts from the European Association of Preventive Cardiology of the European Society of Cardiology were invited to provide a summary and critical review of the most important new studies and evidence since the latest guidelines were published. The structure of the document follows that of the previous document and has six parts: Introduction (epidemiology and cost effectiveness); Cardiovascular risk; How to intervene at the population level; How to intervene at the individual level; Disease-specific interventions; and Settings: where to intervene? In fact, in keeping with the guidelines, greater emphasis has been put on a population-based approach and on disease-specific interventions, avoiding re-interpretation of information already and previously considered. Finally, the presence of several gaps in the knowledge is highlighted.

NT-PROBNP AND THE CUT-OFF VALUE IN CARDIOVASCULAR DISEASES

2011 ◽  
pp. 5-12
Author(s):  
Anh Tien Hoang ◽  
Van Minh Huynh ◽  
Khanh Hoang ◽  
Huu Dang Tran ◽  
Viet An Tran
Keyword(s):  
Heart Failure ◽  
Cardiovascular Disease ◽  
Pilot Study ◽  
Cardiovascular Diseases ◽  
Clinical Application ◽  
European Society ◽  
The Other ◽  
Cardiac Marker ◽  
Cardiac Biomarker ◽  
European Society Of Cardiology

NT-ProBNP is a high value cardiac biomarker and widely applies in many cardiovascular diseases. The evaluation of concentration of NT-ProBNP needs the concern about age, gender, obesity and especially we need each cut-off point for each cause of cardiovascular disease in evaluation and clinical application. Because NT-ProBNP is a new cardiac marker and has been researched in 5 recent years, the cut-off of NT-ProBNP is still being studied for the clinical application in cardiovascular diseases. Only the cut-off of NT-ProBNP in diagnosis heart failure was guided by European Society of Cardiology. The meaning of introduce cut-off value of value plays an role as pilot study for the other relate study and brings the NT-ProBNP closely approach to clinical application.

Sign in / Sign up

Export Citation Format

Share Document